SlideShare a Scribd company logo
1 of 31
The life science business of Merck KGaA,
Darmstadt, Germany operates
as MilliporeSigma in the U.S. and Canada.
Next-Generation Bioprocess Monitoring to Enable Smart
Data Management and Analysis
Hemant Garg
Product Manager, Analytics
The life science business
of Merck KGaA, Darmstadt,
Germany operates as
MilliporeSigma in the U.S.
and Canada
Agenda
1
2 Bioprocessing Data Landscape – Current Challenges and
Needs
Data Management Approaches and Solutions-
Introduction of Bio4CTM ProcessPad
Next Gen Bioprocessing and the BioContinuum™ Platform
3
4
Applications and Use Cases for Bio4CTM
ProcessPad
Next Gen Bioprocessing and the
BioContinuum™ Platform
Speed
Reduce new facility build
times by 70%. Compress
production lead time by
80%.
Quality
10X robustness.
90% reduction in cost of
poor quality.
Flexibility
Reduce product change-over
time by 90%.
Cost
90% reduction in cost to
manufacture and CAPEX.
Business
Drivers
Market
Growth
Uncertainty
New Product
Classes
Cost
Pressure
Market
Trends
How do we react to meet the demands of
today and the future?
* Source: BioPhorum (BPOG)
https://www.biophorum.com/category/resources/technology-roadmapping-resources/introduction/
BioContinuum™
Platform Scope
Process
Analytical
Technologies
Digital
Technologies &
Data Management
Intensified
Processing
Bio4C™ Software Suite
Specifically conceived by industry experts for bioprocess
professionals, the Bio4C™ Software Suite is comprised of
stand-alone, but seamlessly compatible software products.
Their intuitive interfaces and easy access enable a broad
user base to collaborate with global teams across
geographies and organizational silos to control, monitor
and analyse equipment, processes, results, and data in
near real-time.
Based on our core 4C’s: Control, Connect, Collect,
Collaborate, the Bio4C™ Suite offers a convergent, open
digital environment, adaptable to your changing
productivity, process, and regulatory needs.
The Bio4C™ Suite allows for data transparency
and manufacturing intelligence leading to quick
and efficient data-driven decisions for mastery at
the process and plant level.
Addressing customers’ digital transformation needs
Bio4C™ Software Suite
Control
Next generation platform for control
and management of unit operations
Connect
Designed to connect across
the process continuum
Collaborate
Complementary capabilities for collaboration,
remote support and cloud services
Collect
Data collection and advanced analytics
capabilities for rapid process insights
Bioprocessing Data Landscape:
Current Challenges and Needs
Bioprocess Lifecycle
Core functions create and consume data across the process life cycle
Data captured by disparate systems
Bioprocess Data Landscape
Data Stores
MES
LES
eLN
eBR
Custom DB
Data
Warehouse
Data
Historians
QualityControland
Assurance
QA Batch Fitness For Release
Change Control
Management
Process Test Samples
QC Methods
Results
People FitnessTraining
Management
Corrective Action
Management
Corrective Action
Management
Engineering
Equipment Fitness
Maintenance Record
Work Order
LMS – Learning Management System, LIMS – Laboratory Information Management System, QMS –Quality Management
System, BMS - Building Management System, MES – Manufacturing Execution System, LES – Laboratory Execution system,
Asset Mgmt. – Asset Management
Process
Development
Process Fitness
Development Reports
Process Development Experiments
Process
Execution
Process Excursions
and events
Manufacturing
Facility Management
Non-conformance
Management
Environment Fitness
Process Data Batch Report
Investigation Report
eLN
Asset
Mgmt. BMS
eBR
QMS
LMS
LIMS
Data Needs for Investigations and Monitoring
• Integration of data collected from
various work processes
• Paper-based, manual systems
• Other electronic systems
• Process execution workflows
• Process development
• Quality Control and Assurance
• Commercial manufacturing
• Engineering
Engineering
Manufacturing
Investigation
Report
Process Fitness
Experimental Data
Process
Development
Change Control
Management
Test Results
People FitnessTraining
Management
QualityControland
Assurance
Facility Management
Process Data Batch Report
Investigation
Report
Equipment Fitness
Work Order
Regulatory Expectations for Bioprocess Monitoring and Control
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/process-validation-general-principles-and-practices
https://www.ich.org/page/quality-guidelines
Pharmaceutical companies should plan and execute a system for the
monitoring of process performance and product quality to ensure
a state of control is maintained
-ICH Q10
An ongoing program to collect and analyze product and process data
that relate to product quality must be established. The data collected should
include relevant process trends and quality of incoming materials or
components, in-process material, and finished products.
-FDA Process Validation Guidance, Jan 2011
Data Management
Approaches and Solutions:
Introduction to Bio4C™
ProcessPad
Bio4C™ ProcessPad Software
A browser-based platform for data acquisition,
aggregation and process analytics. Built by bioprocess
engineers to manage and analyze your disjoined and
complex process information for a deeper understanding of
your biopharma processes across the process and product
lifecycle in near real-time.
Master your bioprocess
through profound data insights
Through data aggregation, management, visualizations, and analysis,
Bio4C™ ProcessPad makes all critical bioprocess data readily available.
Easy on-demand access to biopharma manufacturing data
Browser-based Platform
Toolset for Efficient Process Troubleshooting
How Bio4CTM ProcessPad Software Helps
Data Archival
Process Monitoring
And Data Analysis
Reporting
and Sharing
Process
Capability
Statistical
Process
Control
1
2
3
Bio4C™ ProcessPad DBProcess Historians
How Bio4CTM ProcessPad Software Helps
Through data aggregation, management, visualizations, and analysis,
Bio4C™ ProcessPad makes all critical bioprocess data readily available.
Process lifecycle management
 Capture all development, scale-up, and commercial data
on one platform
 Simplify tech transfer process
 Access to the latest version of process map
Reporting
 Generate process summary reports
 Create ad-hoc reports required in root cause investigations
 Batch excursion reports, equipment utilization
Continued Process Verification and analytics
 Aggregate real-time and offline process data
 Statistical process control (SPC) and process capability
 Preconfigured trending rules to aid process monitoring
 Process analysis tools to aid investigations & process troubleshooting
 Control limits management
Bio4CTM ProcessPad Software Modules
Trending, Reporting, and Analytics of Machine Data
• Bioreactors
• Chromatography Systems
• CIP Skids
• Buffer Systems
Capture, Trending, Analysis and Reporting of Offline Data
• Offline Batch/Run Data
• Analytical Test Results Data
• SQC, Out-of-trend and Continued Process Verification
Capture, Trending, Analysis and Reporting of Stability
data
• Profile Trending
• Reporting
• Shelf-life prediction
ProcessPad RT
ProcessPad
offline
ProcessPad
stab
Our Software Reliance Program support is provided with all Bio4C™ ProcessPad modules.
Bio4CTM ProcessPad Software Benefits to Customers
• Significant time savings on data hunting & gathering, aggregation, and reporting
• Global teams, CMOs, and suppliers can have browser-based access to data, analytics, and
visualizations
• Single, validated source of data for analytics and process troubleshooting
INDIRECT Benefits
DIRECT Benefits
• Faster closure of investigations & meeting quality metrics
• Faster release of quarantined lots
• Ensure robust supply chain of drugs to patients
• Ensure product consistency and quality compliance
Applications and Use Cases for
Bio4C™ ProcessPad
Common Applications for Bio4C™ ProcessPad
22
Continued Process
Verification
CDMO data
Management
Investigations Process monitoring
Use Case: Continued Process Verification (CPV)
Disparate Data
Sources
Scalability &
Usability
Trust in
Data
Real-time SPC*
Monitoring
Control Limits
Management
Process Summary
Reports
Data assembly and integration
from all sources
Quick deployment and
configuration, easy to learn
Facilitates 21 CFR Part 11
compliance, validated database
Monitoring by exception via
automated alerts - OOT/OOS*
Maintains historical control limits
and process capability indices
Automated scheduled reports
available in a ready-to-use format
Bio4CTM ProcessPad
Solution
 Maintain process in a state of control
throughout the commercial lifecycle
 Know your process, understand the
causes of variation and proactively
reduce where necessary
 Regulatory expectations around CPV
 Regularly trend critical process and
quality parameters and take
corrective actions to address out-of-
trends/process inconsistency
 Develop detailed CPV plan with
regular documentation, reporting, and
reviews and supported by CPV-
informatics framework
Common
Challenges
Customer Needs
* SPC – statistical process control
OOT – Out of Trend
OOS – Out of Specification
Use Case:
CMO/Sponsor Data Sharing and Collaboration
 CMOs* need a platform to aggregate all
manufacturing data and share specific
product data with Sponsors
 Sponsors need to collect manufacturing
data for their products
 Scalable platform to expand the data access
by CMOs to their Sponsors and vice versa
 Multi-party collaboration
(CRO*/CMO/contract labs/Sponsors)
 Easily configurable platform so CMOs can
add new products/Sponsors
 Flexibility on number of users for wider
access without increasing cost
 Platform architecture allows easy access to
external parties
Product Specific
Access
Scalability &
Usability
Product/Process
Configuration
Licensing Model
Sharing Specific
Records
Enables product specific access by CMOs
to Sponsors and vice versa
End-users can easily configure a new
product in a short time frame
Easy deployment & use enables rapid
adoption across the network
Unlimited user/products means wider
data access & collaboration
Browser platform facilitates data sharing
to external parties, zero client footprint
Share specific analysis, dashboards and
routine process execution reports
Bio4CTM ProcessPad
Solution
Common Challenges
Customer Needs
Architecture that
Facilitates Sharing
*CMO – Contract Manufacturing Org
CRO – Contract Research Org
Sponsor 1
Organization
CMO hosts the
Bio4C™ ProcessPad
platform on cloud or
internal IT Network.
CMO provides specific
product data access to
respective sponsor
CMO
Bio4CTM
ProcessPad
Contract Test
Lab A
Sponsor login to
CMO’s Bio4C™
ProcessPad portal
to access or
monitor data
CMO IT Network or Cloud
Sponsor 2
Organization
Sponsor 3
Organization
CMO Hosted Platform with
Access to Multiple Sponsors and Contract Labs
Source: http://processpad.simplyfeye.com/blog21.html
Sponsor
Organization
CMO A
CMO B
Bio4CTM
ProcessPad
Contract Test
Lab A
Sponsor hosts
Bio4C™
ProcessPad
platform on
cloud or internal
IT Network.
Specific product
access and role
to respective
CMO partner
CMO C
CMO-C login to
Sponsor Bio4C™
ProcessPad portal to
upload data
Sponsor IT Network or Cloud
Sponsor Hosted Platform with
Access to Multiple CMOs and Contract Labs
Source: http://processpad.simplyfeye.com/blog21.html
Use Case: Acceleration of Investigations for
Discrepancies
 Process execution data spread across
information silos (ERP, LIMS, Paper
Records, LMS, QMS etc.) requiring huge
effort for data aggregation and analysis
 Ad hoc data assembly often results in poor
quality data with missing context
 Poor investigation outcomes and ineffective
CAPAs
 Delay in closures of investigations and
impact on quality metrics and supply chain
 Cumbersome data sharing methods and
limited cross-functional team collaboration
 Lack of uniformity in investigation
approaches and communications
 Reactive response to process/quality issues
Analysis Speed &
Available Tools
Reactive
Response
Disparate Data
Sources
Siloed Access to
Data & Tools
Impact on Quality
& Supply metrics
Rapid data visualization and analysis
(Timelines, Lot Genealogy, Profile Overlays,
Correlations, etc.)
Automated data assembly & integration in
a single browser window
Proactive response enabled with
automated trend alerts (OOT*)
Unlimited users enables wider platform
access for cross-functional collaboration
Rapid access to data drives effective and
prompt closure of investigations
Data-Driven
Culture
Enables rapid data-driven decision making
for process issues aided by uniformity
Bio4CTM ProcessPad
Solution
Common Challenges
Customer Needs
*OOT – Out of Trend
Use Case: Process Monitoring, Troubleshooting and
Optimization
 Live monitoring of machines only available
on plant floor; not easily accessible to
Process/MSAT Engineers; interfaces lack
analytics capability
 No easy-to-use statistical tools for routine
data analysis to increase process
understanding
 PD, scale-up and manufacturing data
remains scattered
 OOTs often go unnoticed and without
corrective action, it may lead to OOS
 Assembly of process execution data for real
time batch analytics is fragmented leading to
delays in event identification
 80% time spent in assembling data leaving
limited time for analysis for insights
 MSAT must plan experiments to gain
sufficient data for process optimization
Statistical
Tools
Process Lifecycle
Management
Disparate Data
Sources
Machine Data
& Analytics
Process
Understanding
Built-in statistical tools like Profile
Overlays, Correlations, Control charts,
Group Plots, ANOVA etc.
Automatic data assembly & integration
with timely single-window access
Captures all development and commercial
production data on single platform
Access to streaming machine data with
live batch monitoring and statistical
analysis
Time spent on quality analysis leads to
improved process knowledge, proactive
response to issues
Process
Optimization
Reduced MSAT burden for additional
experimentation for at scale/scale down
models
Bio4CTM ProcessPad
Solution
Common ChallengesCustomer Needs
Collaborative and intuitive
manufacturing intelligence
tool for process understanding
Out-of-the-box statistics and
data analysis tools means you
don’t have to be a data scientist to
get the information you need
Significantly increase employee
productivity with increased focus on
process insights and less time
hunting for data
Adaptable to any complexity
in batch manufacturing
process/products
(biologics, vaccines, small
molecules, gene therapies, etc.)
Minimal learning curve – easy to
use, intuitive browser-based
interface
Low maintenance, easy to
deploy, scalable browser-
based platform
Trusted single source of
truth for all process
execution data
Purpose built for the
biopharma industry
designed by bioprocess
engineers
Promote data-driven decision
making culture within
manufacturing and quality
organization
Tool to promote unified
process communication
language at all levels of
the organization
Key Product Highlights
Accessibility to all PD and MFG
data – on a single platform
Vendor agnostic with ability to
connect to multi brand process
equipment and electronic databases
The vibrant M, Millipore, MilliporeSigma, BioContinuum, and Bio4C are trademarks of Merck KGaA, Darmstadt, Germany or its affiliates. All other trademarks are
the property of their respective owners. Detailed information on trademarks is available via publicly accessible resources.
© 2020 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.
Bio4CTM ProcessPad Software Resources
Questions

More Related Content

What's hot

EU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter Validation
EU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter ValidationEU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter Validation
EU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter ValidationMilliporeSigma
 
Single-Use Tangential Flow Filtration for Closed Processing
Single-Use Tangential Flow Filtration for Closed ProcessingSingle-Use Tangential Flow Filtration for Closed Processing
Single-Use Tangential Flow Filtration for Closed ProcessingMerck Life Sciences
 
A Holistic Approach to Upstream Viral Safety
A Holistic Approach to Upstream Viral SafetyA Holistic Approach to Upstream Viral Safety
A Holistic Approach to Upstream Viral SafetyMerck Life Sciences
 
Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)
Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)
Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)MilliporeSigma
 
Challenges using Multiple Single-use Systems: Functionality versus Extractabl...
Challenges using Multiple Single-use Systems: Functionality versus Extractabl...Challenges using Multiple Single-use Systems: Functionality versus Extractabl...
Challenges using Multiple Single-use Systems: Functionality versus Extractabl...Merck Life Sciences
 
Total cost of ownership – how the choice of excipients makes your economics
Total cost of ownership – how the choice of excipients makes your economicsTotal cost of ownership – how the choice of excipients makes your economics
Total cost of ownership – how the choice of excipients makes your economicsMilliporeSigma
 
Using Single-use Technology to Overcome the Challenges of ADC Processing
Using Single-use Technology to Overcome the Challenges of ADC ProcessingUsing Single-use Technology to Overcome the Challenges of ADC Processing
Using Single-use Technology to Overcome the Challenges of ADC ProcessingMerck Life Sciences
 
Validation of Tangential Flow Filtration in Biotech Processes
Validation of Tangential Flow Filtration in Biotech ProcessesValidation of Tangential Flow Filtration in Biotech Processes
Validation of Tangential Flow Filtration in Biotech ProcessesMerck Life Sciences
 
Process Development for Cell Therapy and Viral Gene Therapy
Process Development for Cell Therapy and Viral Gene TherapyProcess Development for Cell Therapy and Viral Gene Therapy
Process Development for Cell Therapy and Viral Gene TherapyMerck Life Sciences
 
Fast-track solutions to address challenges with Host Cell Proteins in early d...
Fast-track solutions to address challenges with Host Cell Proteins in early d...Fast-track solutions to address challenges with Host Cell Proteins in early d...
Fast-track solutions to address challenges with Host Cell Proteins in early d...Merck Life Sciences
 
Beyond Bioprocessing 4.0: The Convergence of IT, OT and Processing Technolog...
Beyond Bioprocessing 4.0:  The Convergence of IT, OT and Processing Technolog...Beyond Bioprocessing 4.0:  The Convergence of IT, OT and Processing Technolog...
Beyond Bioprocessing 4.0: The Convergence of IT, OT and Processing Technolog...Merck Life Sciences
 
Webinar: How to Develop a Regulatory-compliant Continued Process Verificatio...
Webinar: 	How to Develop a Regulatory-compliant Continued Process Verificatio...Webinar: 	How to Develop a Regulatory-compliant Continued Process Verificatio...
Webinar: How to Develop a Regulatory-compliant Continued Process Verificatio...MilliporeSigma
 
Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)
Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)
Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)Merck Life Sciences
 
Membrane Chromatography Solutions for Single-Use, Intensified mAb Purification
Membrane Chromatography Solutions for Single-Use, Intensified mAb PurificationMembrane Chromatography Solutions for Single-Use, Intensified mAb Purification
Membrane Chromatography Solutions for Single-Use, Intensified mAb PurificationMilliporeSigma
 

What's hot (14)

EU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter Validation
EU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter ValidationEU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter Validation
EU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter Validation
 
Single-Use Tangential Flow Filtration for Closed Processing
Single-Use Tangential Flow Filtration for Closed ProcessingSingle-Use Tangential Flow Filtration for Closed Processing
Single-Use Tangential Flow Filtration for Closed Processing
 
A Holistic Approach to Upstream Viral Safety
A Holistic Approach to Upstream Viral SafetyA Holistic Approach to Upstream Viral Safety
A Holistic Approach to Upstream Viral Safety
 
Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)
Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)
Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)
 
Challenges using Multiple Single-use Systems: Functionality versus Extractabl...
Challenges using Multiple Single-use Systems: Functionality versus Extractabl...Challenges using Multiple Single-use Systems: Functionality versus Extractabl...
Challenges using Multiple Single-use Systems: Functionality versus Extractabl...
 
Total cost of ownership – how the choice of excipients makes your economics
Total cost of ownership – how the choice of excipients makes your economicsTotal cost of ownership – how the choice of excipients makes your economics
Total cost of ownership – how the choice of excipients makes your economics
 
Using Single-use Technology to Overcome the Challenges of ADC Processing
Using Single-use Technology to Overcome the Challenges of ADC ProcessingUsing Single-use Technology to Overcome the Challenges of ADC Processing
Using Single-use Technology to Overcome the Challenges of ADC Processing
 
Validation of Tangential Flow Filtration in Biotech Processes
Validation of Tangential Flow Filtration in Biotech ProcessesValidation of Tangential Flow Filtration in Biotech Processes
Validation of Tangential Flow Filtration in Biotech Processes
 
Process Development for Cell Therapy and Viral Gene Therapy
Process Development for Cell Therapy and Viral Gene TherapyProcess Development for Cell Therapy and Viral Gene Therapy
Process Development for Cell Therapy and Viral Gene Therapy
 
Fast-track solutions to address challenges with Host Cell Proteins in early d...
Fast-track solutions to address challenges with Host Cell Proteins in early d...Fast-track solutions to address challenges with Host Cell Proteins in early d...
Fast-track solutions to address challenges with Host Cell Proteins in early d...
 
Beyond Bioprocessing 4.0: The Convergence of IT, OT and Processing Technolog...
Beyond Bioprocessing 4.0:  The Convergence of IT, OT and Processing Technolog...Beyond Bioprocessing 4.0:  The Convergence of IT, OT and Processing Technolog...
Beyond Bioprocessing 4.0: The Convergence of IT, OT and Processing Technolog...
 
Webinar: How to Develop a Regulatory-compliant Continued Process Verificatio...
Webinar: 	How to Develop a Regulatory-compliant Continued Process Verificatio...Webinar: 	How to Develop a Regulatory-compliant Continued Process Verificatio...
Webinar: How to Develop a Regulatory-compliant Continued Process Verificatio...
 
Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)
Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)
Implementing and Managing Pre-use Post-sterilization Integrity Testing (PUPSIT)
 
Membrane Chromatography Solutions for Single-Use, Intensified mAb Purification
Membrane Chromatography Solutions for Single-Use, Intensified mAb PurificationMembrane Chromatography Solutions for Single-Use, Intensified mAb Purification
Membrane Chromatography Solutions for Single-Use, Intensified mAb Purification
 

Similar to Next-Generation Bioprocessing Monitoring to Enable Smart Data Management and Analysis

Smart Data Management and Advanced Analytics with Bio4C™ ProcessPad
Smart Data Management and Advanced Analytics with Bio4C™ ProcessPadSmart Data Management and Advanced Analytics with Bio4C™ ProcessPad
Smart Data Management and Advanced Analytics with Bio4C™ ProcessPadMilliporeSigma
 
Smart Data Management and Advanced Analytics with Bio4C™ ProcessPad
Smart Data Management and Advanced Analytics with Bio4C™ ProcessPadSmart Data Management and Advanced Analytics with Bio4C™ ProcessPad
Smart Data Management and Advanced Analytics with Bio4C™ ProcessPadMerck Life Sciences
 
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...Merck Life Sciences
 
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...MilliporeSigma
 
Transforming Technology Transfer and Recipe Management: From Spreadsheets to ...
Transforming Technology Transfer and Recipe Management: From Spreadsheets to ...Transforming Technology Transfer and Recipe Management: From Spreadsheets to ...
Transforming Technology Transfer and Recipe Management: From Spreadsheets to ...guest070fdd
 
Process Definition Management using ISA-88 and BatchML
Process Definition Management using ISA-88 and BatchMLProcess Definition Management using ISA-88 and BatchML
Process Definition Management using ISA-88 and BatchMLPaul Wlodarczyk
 
Track It, Trace It, Report It
Track It, Trace It, Report ItTrack It, Trace It, Report It
Track It, Trace It, Report ItJason Corder
 
Better Bioprocessing Efficiency Through Centralized Orchestration
Better Bioprocessing Efficiency Through Centralized OrchestrationBetter Bioprocessing Efficiency Through Centralized Orchestration
Better Bioprocessing Efficiency Through Centralized OrchestrationMerck Life Sciences
 
Better Bioprocessing Efficiency Through Centralized Orchestration
Better Bioprocessing Efficiency Through Centralized OrchestrationBetter Bioprocessing Efficiency Through Centralized Orchestration
Better Bioprocessing Efficiency Through Centralized OrchestrationMilliporeSigma
 
BILS 2015 Umetrics Stefan Raennar
BILS 2015 Umetrics Stefan RaennarBILS 2015 Umetrics Stefan Raennar
BILS 2015 Umetrics Stefan RaennarGBX Events
 
Industrial Bioprocessing webinar.pptx
Industrial Bioprocessing webinar.pptxIndustrial Bioprocessing webinar.pptx
Industrial Bioprocessing webinar.pptxShubham Chinchulkar
 
Idbs Bioprocess Execution System
Idbs Bioprocess Execution SystemIdbs Bioprocess Execution System
Idbs Bioprocess Execution Systemmmcriley
 
Data Integrity webinar - Essentials & Solutions
Data Integrity webinar - Essentials & SolutionsData Integrity webinar - Essentials & Solutions
Data Integrity webinar - Essentials & Solutionspi
 
Next Generation Bioprocessing adoption for mAbs – BioContinuum™ Platform Info...
Next Generation Bioprocessing adoption for mAbs – BioContinuum™ Platform Info...Next Generation Bioprocessing adoption for mAbs – BioContinuum™ Platform Info...
Next Generation Bioprocessing adoption for mAbs – BioContinuum™ Platform Info...Merck Life Sciences
 
SAP in Pharmaceutical Industry
SAP in Pharmaceutical IndustrySAP in Pharmaceutical Industry
SAP in Pharmaceutical IndustryChandra Shekar
 
(1)Statistics in QbD Stats WS 09-06.ppt
(1)Statistics in QbD Stats WS 09-06.ppt(1)Statistics in QbD Stats WS 09-06.ppt
(1)Statistics in QbD Stats WS 09-06.pptDiptoKumerSarker1
 
Medical OEMs can achieve commercial mfg efficiency
Medical OEMs can achieve commercial mfg efficiencyMedical OEMs can achieve commercial mfg efficiency
Medical OEMs can achieve commercial mfg efficiencysmclacken
 
Regulatory expectation & design approach on continuous process verification
Regulatory expectation & design approach on continuous process verificationRegulatory expectation & design approach on continuous process verification
Regulatory expectation & design approach on continuous process verificationKaran Rajendra Khairnar
 

Similar to Next-Generation Bioprocessing Monitoring to Enable Smart Data Management and Analysis (20)

Smart Data Management and Advanced Analytics with Bio4C™ ProcessPad
Smart Data Management and Advanced Analytics with Bio4C™ ProcessPadSmart Data Management and Advanced Analytics with Bio4C™ ProcessPad
Smart Data Management and Advanced Analytics with Bio4C™ ProcessPad
 
Smart Data Management and Advanced Analytics with Bio4C™ ProcessPad
Smart Data Management and Advanced Analytics with Bio4C™ ProcessPadSmart Data Management and Advanced Analytics with Bio4C™ ProcessPad
Smart Data Management and Advanced Analytics with Bio4C™ ProcessPad
 
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
 
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
 
Transforming Technology Transfer and Recipe Management: From Spreadsheets to ...
Transforming Technology Transfer and Recipe Management: From Spreadsheets to ...Transforming Technology Transfer and Recipe Management: From Spreadsheets to ...
Transforming Technology Transfer and Recipe Management: From Spreadsheets to ...
 
MES systems
MES systemsMES systems
MES systems
 
Process Definition Management using ISA-88 and BatchML
Process Definition Management using ISA-88 and BatchMLProcess Definition Management using ISA-88 and BatchML
Process Definition Management using ISA-88 and BatchML
 
Track It, Trace It, Report It
Track It, Trace It, Report ItTrack It, Trace It, Report It
Track It, Trace It, Report It
 
Better Bioprocessing Efficiency Through Centralized Orchestration
Better Bioprocessing Efficiency Through Centralized OrchestrationBetter Bioprocessing Efficiency Through Centralized Orchestration
Better Bioprocessing Efficiency Through Centralized Orchestration
 
Better Bioprocessing Efficiency Through Centralized Orchestration
Better Bioprocessing Efficiency Through Centralized OrchestrationBetter Bioprocessing Efficiency Through Centralized Orchestration
Better Bioprocessing Efficiency Through Centralized Orchestration
 
BILS 2015 Umetrics Stefan Raennar
BILS 2015 Umetrics Stefan RaennarBILS 2015 Umetrics Stefan Raennar
BILS 2015 Umetrics Stefan Raennar
 
Industrial Bioprocessing webinar.pptx
Industrial Bioprocessing webinar.pptxIndustrial Bioprocessing webinar.pptx
Industrial Bioprocessing webinar.pptx
 
Idbs Bioprocess Execution System
Idbs Bioprocess Execution SystemIdbs Bioprocess Execution System
Idbs Bioprocess Execution System
 
Data Integrity webinar - Essentials & Solutions
Data Integrity webinar - Essentials & SolutionsData Integrity webinar - Essentials & Solutions
Data Integrity webinar - Essentials & Solutions
 
Next Generation Bioprocessing adoption for mAbs – BioContinuum™ Platform Info...
Next Generation Bioprocessing adoption for mAbs – BioContinuum™ Platform Info...Next Generation Bioprocessing adoption for mAbs – BioContinuum™ Platform Info...
Next Generation Bioprocessing adoption for mAbs – BioContinuum™ Platform Info...
 
SAP in Pharmaceutical Industry
SAP in Pharmaceutical IndustrySAP in Pharmaceutical Industry
SAP in Pharmaceutical Industry
 
Transforming an Enterprise with Business Process Solutions
Transforming an Enterprise with Business Process SolutionsTransforming an Enterprise with Business Process Solutions
Transforming an Enterprise with Business Process Solutions
 
(1)Statistics in QbD Stats WS 09-06.ppt
(1)Statistics in QbD Stats WS 09-06.ppt(1)Statistics in QbD Stats WS 09-06.ppt
(1)Statistics in QbD Stats WS 09-06.ppt
 
Medical OEMs can achieve commercial mfg efficiency
Medical OEMs can achieve commercial mfg efficiencyMedical OEMs can achieve commercial mfg efficiency
Medical OEMs can achieve commercial mfg efficiency
 
Regulatory expectation & design approach on continuous process verification
Regulatory expectation & design approach on continuous process verificationRegulatory expectation & design approach on continuous process verification
Regulatory expectation & design approach on continuous process verification
 

More from MilliporeSigma

Launch of our new Titanium Dioxide Alternative
Launch of our new Titanium Dioxide AlternativeLaunch of our new Titanium Dioxide Alternative
Launch of our new Titanium Dioxide AlternativeMilliporeSigma
 
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...MilliporeSigma
 
Use of Excipients in Downstream Processing to Improve Protein Purification
Use of Excipients in Downstream Processing to Improve Protein PurificationUse of Excipients in Downstream Processing to Improve Protein Purification
Use of Excipients in Downstream Processing to Improve Protein PurificationMilliporeSigma
 
Exploring the protein stabilizing capability of surfactants against agitation...
Exploring the protein stabilizing capability of surfactants against agitation...Exploring the protein stabilizing capability of surfactants against agitation...
Exploring the protein stabilizing capability of surfactants against agitation...MilliporeSigma
 
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...MilliporeSigma
 
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...MilliporeSigma
 
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...MilliporeSigma
 
The Future of Pharma- and Biopharmaceutical Audits
The Future of Pharma- and Biopharmaceutical AuditsThe Future of Pharma- and Biopharmaceutical Audits
The Future of Pharma- and Biopharmaceutical AuditsMilliporeSigma
 
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...MilliporeSigma
 
Identity testing by NGS as a means of risk mitigation for viral gene therapies
Identity testing by NGS as a means of risk mitigation for viral gene therapiesIdentity testing by NGS as a means of risk mitigation for viral gene therapies
Identity testing by NGS as a means of risk mitigation for viral gene therapiesMilliporeSigma
 
Latest advancements of melt based 3D printing technologies for oral drug deli...
Latest advancements of melt based 3D printing technologies for oral drug deli...Latest advancements of melt based 3D printing technologies for oral drug deli...
Latest advancements of melt based 3D printing technologies for oral drug deli...MilliporeSigma
 
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...MilliporeSigma
 
How does the ICH Q5A revision impact viral safety strategies for biologics?
How does the ICH Q5A revision impact viral safety strategies for biologics?How does the ICH Q5A revision impact viral safety strategies for biologics?
How does the ICH Q5A revision impact viral safety strategies for biologics?MilliporeSigma
 
Insights from a Global Collaboration Accelerating Vaccine Development with an...
Insights from a Global Collaboration Accelerating Vaccine Development with an...Insights from a Global Collaboration Accelerating Vaccine Development with an...
Insights from a Global Collaboration Accelerating Vaccine Development with an...MilliporeSigma
 
Risk-Based Qualification of X-Ray Sterilization for Single-Use Systems
Risk-Based Qualification of X-Ray Sterilization for Single-Use SystemsRisk-Based Qualification of X-Ray Sterilization for Single-Use Systems
Risk-Based Qualification of X-Ray Sterilization for Single-Use SystemsMilliporeSigma
 
Rapid Replication Competent Adenovirus (rRCA) Detection: Accelerate your Lot ...
Rapid Replication Competent Adenovirus (rRCA) Detection: Accelerate your Lot ...Rapid Replication Competent Adenovirus (rRCA) Detection: Accelerate your Lot ...
Rapid Replication Competent Adenovirus (rRCA) Detection: Accelerate your Lot ...MilliporeSigma
 
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...MilliporeSigma
 
The Developability Classification System (DCS): Enabling an Optimized Approac...
The Developability Classification System (DCS): Enabling an Optimized Approac...The Developability Classification System (DCS): Enabling an Optimized Approac...
The Developability Classification System (DCS): Enabling an Optimized Approac...MilliporeSigma
 
How to Accelerate and Enhance ADC Therapies
How to Accelerate and Enhance ADC TherapiesHow to Accelerate and Enhance ADC Therapies
How to Accelerate and Enhance ADC TherapiesMilliporeSigma
 
EU GMP Annex 1 Draft - Closed System Design Consideration with Single-Use Sys...
EU GMP Annex 1 Draft - Closed System Design Consideration with Single-Use Sys...EU GMP Annex 1 Draft - Closed System Design Consideration with Single-Use Sys...
EU GMP Annex 1 Draft - Closed System Design Consideration with Single-Use Sys...MilliporeSigma
 

More from MilliporeSigma (20)

Launch of our new Titanium Dioxide Alternative
Launch of our new Titanium Dioxide AlternativeLaunch of our new Titanium Dioxide Alternative
Launch of our new Titanium Dioxide Alternative
 
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
 
Use of Excipients in Downstream Processing to Improve Protein Purification
Use of Excipients in Downstream Processing to Improve Protein PurificationUse of Excipients in Downstream Processing to Improve Protein Purification
Use of Excipients in Downstream Processing to Improve Protein Purification
 
Exploring the protein stabilizing capability of surfactants against agitation...
Exploring the protein stabilizing capability of surfactants against agitation...Exploring the protein stabilizing capability of surfactants against agitation...
Exploring the protein stabilizing capability of surfactants against agitation...
 
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
 
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
 
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
 
The Future of Pharma- and Biopharmaceutical Audits
The Future of Pharma- and Biopharmaceutical AuditsThe Future of Pharma- and Biopharmaceutical Audits
The Future of Pharma- and Biopharmaceutical Audits
 
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
 
Identity testing by NGS as a means of risk mitigation for viral gene therapies
Identity testing by NGS as a means of risk mitigation for viral gene therapiesIdentity testing by NGS as a means of risk mitigation for viral gene therapies
Identity testing by NGS as a means of risk mitigation for viral gene therapies
 
Latest advancements of melt based 3D printing technologies for oral drug deli...
Latest advancements of melt based 3D printing technologies for oral drug deli...Latest advancements of melt based 3D printing technologies for oral drug deli...
Latest advancements of melt based 3D printing technologies for oral drug deli...
 
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
 
How does the ICH Q5A revision impact viral safety strategies for biologics?
How does the ICH Q5A revision impact viral safety strategies for biologics?How does the ICH Q5A revision impact viral safety strategies for biologics?
How does the ICH Q5A revision impact viral safety strategies for biologics?
 
Insights from a Global Collaboration Accelerating Vaccine Development with an...
Insights from a Global Collaboration Accelerating Vaccine Development with an...Insights from a Global Collaboration Accelerating Vaccine Development with an...
Insights from a Global Collaboration Accelerating Vaccine Development with an...
 
Risk-Based Qualification of X-Ray Sterilization for Single-Use Systems
Risk-Based Qualification of X-Ray Sterilization for Single-Use SystemsRisk-Based Qualification of X-Ray Sterilization for Single-Use Systems
Risk-Based Qualification of X-Ray Sterilization for Single-Use Systems
 
Rapid Replication Competent Adenovirus (rRCA) Detection: Accelerate your Lot ...
Rapid Replication Competent Adenovirus (rRCA) Detection: Accelerate your Lot ...Rapid Replication Competent Adenovirus (rRCA) Detection: Accelerate your Lot ...
Rapid Replication Competent Adenovirus (rRCA) Detection: Accelerate your Lot ...
 
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
 
The Developability Classification System (DCS): Enabling an Optimized Approac...
The Developability Classification System (DCS): Enabling an Optimized Approac...The Developability Classification System (DCS): Enabling an Optimized Approac...
The Developability Classification System (DCS): Enabling an Optimized Approac...
 
How to Accelerate and Enhance ADC Therapies
How to Accelerate and Enhance ADC TherapiesHow to Accelerate and Enhance ADC Therapies
How to Accelerate and Enhance ADC Therapies
 
EU GMP Annex 1 Draft - Closed System Design Consideration with Single-Use Sys...
EU GMP Annex 1 Draft - Closed System Design Consideration with Single-Use Sys...EU GMP Annex 1 Draft - Closed System Design Consideration with Single-Use Sys...
EU GMP Annex 1 Draft - Closed System Design Consideration with Single-Use Sys...
 

Recently uploaded

Single Assessment Framework - What We Know So Far
Single Assessment Framework - What We Know So FarSingle Assessment Framework - What We Know So Far
Single Assessment Framework - What We Know So FarCareLineLive
 
Call Girl Gurgaon Saloni 9711199012 Independent Escort Service Gurgaon
Call Girl Gurgaon Saloni 9711199012 Independent Escort Service GurgaonCall Girl Gurgaon Saloni 9711199012 Independent Escort Service Gurgaon
Call Girl Gurgaon Saloni 9711199012 Independent Escort Service GurgaonCall Girls Service Gurgaon
 
Experience learning - lessons from 25 years of ATACC - Mark Forrest and Halde...
Experience learning - lessons from 25 years of ATACC - Mark Forrest and Halde...Experience learning - lessons from 25 years of ATACC - Mark Forrest and Halde...
Experience learning - lessons from 25 years of ATACC - Mark Forrest and Halde...scanFOAM
 
Call Girls LB Nagar 7001305949 all area service COD available Any Time
Call Girls LB Nagar 7001305949 all area service COD available Any TimeCall Girls LB Nagar 7001305949 all area service COD available Any Time
Call Girls LB Nagar 7001305949 all area service COD available Any Timedelhimodelshub1
 
Call Girl Chandigarh Mallika ❤️🍑 9907093804 👄🫦 Independent Escort Service Cha...
Call Girl Chandigarh Mallika ❤️🍑 9907093804 👄🫦 Independent Escort Service Cha...Call Girl Chandigarh Mallika ❤️🍑 9907093804 👄🫦 Independent Escort Service Cha...
Call Girl Chandigarh Mallika ❤️🍑 9907093804 👄🫦 Independent Escort Service Cha...High Profile Call Girls Chandigarh Aarushi
 
College Call Girls Hyderabad Sakshi 9907093804 Independent Escort Service Hyd...
College Call Girls Hyderabad Sakshi 9907093804 Independent Escort Service Hyd...College Call Girls Hyderabad Sakshi 9907093804 Independent Escort Service Hyd...
College Call Girls Hyderabad Sakshi 9907093804 Independent Escort Service Hyd...delhimodelshub1
 
Russian Call Girls in Hyderabad Ishita 9907093804 Independent Escort Service ...
Russian Call Girls in Hyderabad Ishita 9907093804 Independent Escort Service ...Russian Call Girls in Hyderabad Ishita 9907093804 Independent Escort Service ...
Russian Call Girls in Hyderabad Ishita 9907093804 Independent Escort Service ...delhimodelshub1
 
Housewife Call Girls Nandini Layout - Phone No 7001305949 For Ultimate Sexual...
Housewife Call Girls Nandini Layout - Phone No 7001305949 For Ultimate Sexual...Housewife Call Girls Nandini Layout - Phone No 7001305949 For Ultimate Sexual...
Housewife Call Girls Nandini Layout - Phone No 7001305949 For Ultimate Sexual...narwatsonia7
 
Russian Escorts Delhi | 9711199171 | all area service available
Russian Escorts Delhi | 9711199171 | all area service availableRussian Escorts Delhi | 9711199171 | all area service available
Russian Escorts Delhi | 9711199171 | all area service availablesandeepkumar69420
 
Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...
Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...
Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...High Profile Call Girls Chandigarh Aarushi
 
Basics of Anatomy- Language of Anatomy.pptx
Basics of Anatomy- Language of Anatomy.pptxBasics of Anatomy- Language of Anatomy.pptx
Basics of Anatomy- Language of Anatomy.pptxAyush Gupta
 
Call Girls Kukatpally 7001305949 all area service COD available Any Time
Call Girls Kukatpally 7001305949 all area service COD available Any TimeCall Girls Kukatpally 7001305949 all area service COD available Any Time
Call Girls Kukatpally 7001305949 all area service COD available Any Timedelhimodelshub1
 
2025 Inpatient Prospective Payment System (IPPS) Proposed Rule
2025 Inpatient Prospective Payment System (IPPS) Proposed Rule2025 Inpatient Prospective Payment System (IPPS) Proposed Rule
2025 Inpatient Prospective Payment System (IPPS) Proposed RuleShelby Lewis
 
Gurgaon Sector 90 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
Gurgaon Sector 90 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...Gurgaon Sector 90 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
Gurgaon Sector 90 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...ggsonu500
 

Recently uploaded (20)

College Call Girls Dehradun Kavya 🔝 7001305949 🔝 📍 Independent Escort Service...
College Call Girls Dehradun Kavya 🔝 7001305949 🔝 📍 Independent Escort Service...College Call Girls Dehradun Kavya 🔝 7001305949 🔝 📍 Independent Escort Service...
College Call Girls Dehradun Kavya 🔝 7001305949 🔝 📍 Independent Escort Service...
 
Single Assessment Framework - What We Know So Far
Single Assessment Framework - What We Know So FarSingle Assessment Framework - What We Know So Far
Single Assessment Framework - What We Know So Far
 
Call Girl Gurgaon Saloni 9711199012 Independent Escort Service Gurgaon
Call Girl Gurgaon Saloni 9711199012 Independent Escort Service GurgaonCall Girl Gurgaon Saloni 9711199012 Independent Escort Service Gurgaon
Call Girl Gurgaon Saloni 9711199012 Independent Escort Service Gurgaon
 
Experience learning - lessons from 25 years of ATACC - Mark Forrest and Halde...
Experience learning - lessons from 25 years of ATACC - Mark Forrest and Halde...Experience learning - lessons from 25 years of ATACC - Mark Forrest and Halde...
Experience learning - lessons from 25 years of ATACC - Mark Forrest and Halde...
 
Call Girls LB Nagar 7001305949 all area service COD available Any Time
Call Girls LB Nagar 7001305949 all area service COD available Any TimeCall Girls LB Nagar 7001305949 all area service COD available Any Time
Call Girls LB Nagar 7001305949 all area service COD available Any Time
 
Call Girl Chandigarh Mallika ❤️🍑 9907093804 👄🫦 Independent Escort Service Cha...
Call Girl Chandigarh Mallika ❤️🍑 9907093804 👄🫦 Independent Escort Service Cha...Call Girl Chandigarh Mallika ❤️🍑 9907093804 👄🫦 Independent Escort Service Cha...
Call Girl Chandigarh Mallika ❤️🍑 9907093804 👄🫦 Independent Escort Service Cha...
 
College Call Girls Hyderabad Sakshi 9907093804 Independent Escort Service Hyd...
College Call Girls Hyderabad Sakshi 9907093804 Independent Escort Service Hyd...College Call Girls Hyderabad Sakshi 9907093804 Independent Escort Service Hyd...
College Call Girls Hyderabad Sakshi 9907093804 Independent Escort Service Hyd...
 
Russian Call Girls in Hyderabad Ishita 9907093804 Independent Escort Service ...
Russian Call Girls in Hyderabad Ishita 9907093804 Independent Escort Service ...Russian Call Girls in Hyderabad Ishita 9907093804 Independent Escort Service ...
Russian Call Girls in Hyderabad Ishita 9907093804 Independent Escort Service ...
 
Housewife Call Girls Nandini Layout - Phone No 7001305949 For Ultimate Sexual...
Housewife Call Girls Nandini Layout - Phone No 7001305949 For Ultimate Sexual...Housewife Call Girls Nandini Layout - Phone No 7001305949 For Ultimate Sexual...
Housewife Call Girls Nandini Layout - Phone No 7001305949 For Ultimate Sexual...
 
Russian Escorts Delhi | 9711199171 | all area service available
Russian Escorts Delhi | 9711199171 | all area service availableRussian Escorts Delhi | 9711199171 | all area service available
Russian Escorts Delhi | 9711199171 | all area service available
 
VIP Call Girls Lucknow Isha 🔝 9719455033 🔝 🎶 Independent Escort Service Lucknow
VIP Call Girls Lucknow Isha 🔝 9719455033 🔝 🎶 Independent Escort Service LucknowVIP Call Girls Lucknow Isha 🔝 9719455033 🔝 🎶 Independent Escort Service Lucknow
VIP Call Girls Lucknow Isha 🔝 9719455033 🔝 🎶 Independent Escort Service Lucknow
 
Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...
Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...
Russian Call Girls in Chandigarh Ojaswi ❤️🍑 9907093804 👄🫦 Independent Escort ...
 
Call Girls in Lucknow Esha 🔝 8923113531 🔝 🎶 Independent Escort Service Lucknow
Call Girls in Lucknow Esha 🔝 8923113531  🔝 🎶 Independent Escort Service LucknowCall Girls in Lucknow Esha 🔝 8923113531  🔝 🎶 Independent Escort Service Lucknow
Call Girls in Lucknow Esha 🔝 8923113531 🔝 🎶 Independent Escort Service Lucknow
 
Russian Call Girls South Delhi 9711199171 discount on your booking
Russian Call Girls South Delhi 9711199171 discount on your bookingRussian Call Girls South Delhi 9711199171 discount on your booking
Russian Call Girls South Delhi 9711199171 discount on your booking
 
Basics of Anatomy- Language of Anatomy.pptx
Basics of Anatomy- Language of Anatomy.pptxBasics of Anatomy- Language of Anatomy.pptx
Basics of Anatomy- Language of Anatomy.pptx
 
Call Girl Dehradun Aashi 🔝 7001305949 🔝 💃 Independent Escort Service Dehradun
Call Girl Dehradun Aashi 🔝 7001305949 🔝 💃 Independent Escort Service DehradunCall Girl Dehradun Aashi 🔝 7001305949 🔝 💃 Independent Escort Service Dehradun
Call Girl Dehradun Aashi 🔝 7001305949 🔝 💃 Independent Escort Service Dehradun
 
Call Girls Kukatpally 7001305949 all area service COD available Any Time
Call Girls Kukatpally 7001305949 all area service COD available Any TimeCall Girls Kukatpally 7001305949 all area service COD available Any Time
Call Girls Kukatpally 7001305949 all area service COD available Any Time
 
2025 Inpatient Prospective Payment System (IPPS) Proposed Rule
2025 Inpatient Prospective Payment System (IPPS) Proposed Rule2025 Inpatient Prospective Payment System (IPPS) Proposed Rule
2025 Inpatient Prospective Payment System (IPPS) Proposed Rule
 
Gurgaon Sector 90 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
Gurgaon Sector 90 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...Gurgaon Sector 90 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
Gurgaon Sector 90 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
 
Call Girl Guwahati Aashi 👉 7001305949 👈 🔝 Independent Escort Service Guwahati
Call Girl Guwahati Aashi 👉 7001305949 👈 🔝 Independent Escort Service GuwahatiCall Girl Guwahati Aashi 👉 7001305949 👈 🔝 Independent Escort Service Guwahati
Call Girl Guwahati Aashi 👉 7001305949 👈 🔝 Independent Escort Service Guwahati
 

Next-Generation Bioprocessing Monitoring to Enable Smart Data Management and Analysis

  • 1. The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada. Next-Generation Bioprocess Monitoring to Enable Smart Data Management and Analysis Hemant Garg Product Manager, Analytics
  • 2. The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada
  • 3. Agenda 1 2 Bioprocessing Data Landscape – Current Challenges and Needs Data Management Approaches and Solutions- Introduction of Bio4CTM ProcessPad Next Gen Bioprocessing and the BioContinuum™ Platform 3 4 Applications and Use Cases for Bio4CTM ProcessPad
  • 4. Next Gen Bioprocessing and the BioContinuum™ Platform
  • 5. Speed Reduce new facility build times by 70%. Compress production lead time by 80%. Quality 10X robustness. 90% reduction in cost of poor quality. Flexibility Reduce product change-over time by 90%. Cost 90% reduction in cost to manufacture and CAPEX. Business Drivers Market Growth Uncertainty New Product Classes Cost Pressure Market Trends How do we react to meet the demands of today and the future? * Source: BioPhorum (BPOG) https://www.biophorum.com/category/resources/technology-roadmapping-resources/introduction/ BioContinuum™ Platform Scope Process Analytical Technologies Digital Technologies & Data Management Intensified Processing
  • 6. Bio4C™ Software Suite Specifically conceived by industry experts for bioprocess professionals, the Bio4C™ Software Suite is comprised of stand-alone, but seamlessly compatible software products. Their intuitive interfaces and easy access enable a broad user base to collaborate with global teams across geographies and organizational silos to control, monitor and analyse equipment, processes, results, and data in near real-time. Based on our core 4C’s: Control, Connect, Collect, Collaborate, the Bio4C™ Suite offers a convergent, open digital environment, adaptable to your changing productivity, process, and regulatory needs. The Bio4C™ Suite allows for data transparency and manufacturing intelligence leading to quick and efficient data-driven decisions for mastery at the process and plant level.
  • 7. Addressing customers’ digital transformation needs Bio4C™ Software Suite Control Next generation platform for control and management of unit operations Connect Designed to connect across the process continuum Collaborate Complementary capabilities for collaboration, remote support and cloud services Collect Data collection and advanced analytics capabilities for rapid process insights
  • 9. Bioprocess Lifecycle Core functions create and consume data across the process life cycle
  • 10. Data captured by disparate systems Bioprocess Data Landscape Data Stores MES LES eLN eBR Custom DB Data Warehouse Data Historians QualityControland Assurance QA Batch Fitness For Release Change Control Management Process Test Samples QC Methods Results People FitnessTraining Management Corrective Action Management Corrective Action Management Engineering Equipment Fitness Maintenance Record Work Order LMS – Learning Management System, LIMS – Laboratory Information Management System, QMS –Quality Management System, BMS - Building Management System, MES – Manufacturing Execution System, LES – Laboratory Execution system, Asset Mgmt. – Asset Management Process Development Process Fitness Development Reports Process Development Experiments Process Execution Process Excursions and events Manufacturing Facility Management Non-conformance Management Environment Fitness Process Data Batch Report Investigation Report eLN Asset Mgmt. BMS eBR QMS LMS LIMS
  • 11. Data Needs for Investigations and Monitoring • Integration of data collected from various work processes • Paper-based, manual systems • Other electronic systems • Process execution workflows • Process development • Quality Control and Assurance • Commercial manufacturing • Engineering Engineering Manufacturing Investigation Report Process Fitness Experimental Data Process Development Change Control Management Test Results People FitnessTraining Management QualityControland Assurance Facility Management Process Data Batch Report Investigation Report Equipment Fitness Work Order
  • 12. Regulatory Expectations for Bioprocess Monitoring and Control https://www.fda.gov/regulatory-information/search-fda-guidance-documents/process-validation-general-principles-and-practices https://www.ich.org/page/quality-guidelines Pharmaceutical companies should plan and execute a system for the monitoring of process performance and product quality to ensure a state of control is maintained -ICH Q10 An ongoing program to collect and analyze product and process data that relate to product quality must be established. The data collected should include relevant process trends and quality of incoming materials or components, in-process material, and finished products. -FDA Process Validation Guidance, Jan 2011
  • 13. Data Management Approaches and Solutions: Introduction to Bio4C™ ProcessPad
  • 14. Bio4C™ ProcessPad Software A browser-based platform for data acquisition, aggregation and process analytics. Built by bioprocess engineers to manage and analyze your disjoined and complex process information for a deeper understanding of your biopharma processes across the process and product lifecycle in near real-time. Master your bioprocess through profound data insights
  • 15. Through data aggregation, management, visualizations, and analysis, Bio4C™ ProcessPad makes all critical bioprocess data readily available. Easy on-demand access to biopharma manufacturing data Browser-based Platform
  • 16. Toolset for Efficient Process Troubleshooting
  • 17. How Bio4CTM ProcessPad Software Helps Data Archival Process Monitoring And Data Analysis Reporting and Sharing Process Capability Statistical Process Control 1 2 3 Bio4C™ ProcessPad DBProcess Historians
  • 18. How Bio4CTM ProcessPad Software Helps Through data aggregation, management, visualizations, and analysis, Bio4C™ ProcessPad makes all critical bioprocess data readily available. Process lifecycle management  Capture all development, scale-up, and commercial data on one platform  Simplify tech transfer process  Access to the latest version of process map Reporting  Generate process summary reports  Create ad-hoc reports required in root cause investigations  Batch excursion reports, equipment utilization Continued Process Verification and analytics  Aggregate real-time and offline process data  Statistical process control (SPC) and process capability  Preconfigured trending rules to aid process monitoring  Process analysis tools to aid investigations & process troubleshooting  Control limits management
  • 19. Bio4CTM ProcessPad Software Modules Trending, Reporting, and Analytics of Machine Data • Bioreactors • Chromatography Systems • CIP Skids • Buffer Systems Capture, Trending, Analysis and Reporting of Offline Data • Offline Batch/Run Data • Analytical Test Results Data • SQC, Out-of-trend and Continued Process Verification Capture, Trending, Analysis and Reporting of Stability data • Profile Trending • Reporting • Shelf-life prediction ProcessPad RT ProcessPad offline ProcessPad stab Our Software Reliance Program support is provided with all Bio4C™ ProcessPad modules.
  • 20. Bio4CTM ProcessPad Software Benefits to Customers • Significant time savings on data hunting & gathering, aggregation, and reporting • Global teams, CMOs, and suppliers can have browser-based access to data, analytics, and visualizations • Single, validated source of data for analytics and process troubleshooting INDIRECT Benefits DIRECT Benefits • Faster closure of investigations & meeting quality metrics • Faster release of quarantined lots • Ensure robust supply chain of drugs to patients • Ensure product consistency and quality compliance
  • 21. Applications and Use Cases for Bio4C™ ProcessPad
  • 22. Common Applications for Bio4C™ ProcessPad 22 Continued Process Verification CDMO data Management Investigations Process monitoring
  • 23. Use Case: Continued Process Verification (CPV) Disparate Data Sources Scalability & Usability Trust in Data Real-time SPC* Monitoring Control Limits Management Process Summary Reports Data assembly and integration from all sources Quick deployment and configuration, easy to learn Facilitates 21 CFR Part 11 compliance, validated database Monitoring by exception via automated alerts - OOT/OOS* Maintains historical control limits and process capability indices Automated scheduled reports available in a ready-to-use format Bio4CTM ProcessPad Solution  Maintain process in a state of control throughout the commercial lifecycle  Know your process, understand the causes of variation and proactively reduce where necessary  Regulatory expectations around CPV  Regularly trend critical process and quality parameters and take corrective actions to address out-of- trends/process inconsistency  Develop detailed CPV plan with regular documentation, reporting, and reviews and supported by CPV- informatics framework Common Challenges Customer Needs * SPC – statistical process control OOT – Out of Trend OOS – Out of Specification
  • 24. Use Case: CMO/Sponsor Data Sharing and Collaboration  CMOs* need a platform to aggregate all manufacturing data and share specific product data with Sponsors  Sponsors need to collect manufacturing data for their products  Scalable platform to expand the data access by CMOs to their Sponsors and vice versa  Multi-party collaboration (CRO*/CMO/contract labs/Sponsors)  Easily configurable platform so CMOs can add new products/Sponsors  Flexibility on number of users for wider access without increasing cost  Platform architecture allows easy access to external parties Product Specific Access Scalability & Usability Product/Process Configuration Licensing Model Sharing Specific Records Enables product specific access by CMOs to Sponsors and vice versa End-users can easily configure a new product in a short time frame Easy deployment & use enables rapid adoption across the network Unlimited user/products means wider data access & collaboration Browser platform facilitates data sharing to external parties, zero client footprint Share specific analysis, dashboards and routine process execution reports Bio4CTM ProcessPad Solution Common Challenges Customer Needs Architecture that Facilitates Sharing *CMO – Contract Manufacturing Org CRO – Contract Research Org
  • 25. Sponsor 1 Organization CMO hosts the Bio4C™ ProcessPad platform on cloud or internal IT Network. CMO provides specific product data access to respective sponsor CMO Bio4CTM ProcessPad Contract Test Lab A Sponsor login to CMO’s Bio4C™ ProcessPad portal to access or monitor data CMO IT Network or Cloud Sponsor 2 Organization Sponsor 3 Organization CMO Hosted Platform with Access to Multiple Sponsors and Contract Labs Source: http://processpad.simplyfeye.com/blog21.html
  • 26. Sponsor Organization CMO A CMO B Bio4CTM ProcessPad Contract Test Lab A Sponsor hosts Bio4C™ ProcessPad platform on cloud or internal IT Network. Specific product access and role to respective CMO partner CMO C CMO-C login to Sponsor Bio4C™ ProcessPad portal to upload data Sponsor IT Network or Cloud Sponsor Hosted Platform with Access to Multiple CMOs and Contract Labs Source: http://processpad.simplyfeye.com/blog21.html
  • 27. Use Case: Acceleration of Investigations for Discrepancies  Process execution data spread across information silos (ERP, LIMS, Paper Records, LMS, QMS etc.) requiring huge effort for data aggregation and analysis  Ad hoc data assembly often results in poor quality data with missing context  Poor investigation outcomes and ineffective CAPAs  Delay in closures of investigations and impact on quality metrics and supply chain  Cumbersome data sharing methods and limited cross-functional team collaboration  Lack of uniformity in investigation approaches and communications  Reactive response to process/quality issues Analysis Speed & Available Tools Reactive Response Disparate Data Sources Siloed Access to Data & Tools Impact on Quality & Supply metrics Rapid data visualization and analysis (Timelines, Lot Genealogy, Profile Overlays, Correlations, etc.) Automated data assembly & integration in a single browser window Proactive response enabled with automated trend alerts (OOT*) Unlimited users enables wider platform access for cross-functional collaboration Rapid access to data drives effective and prompt closure of investigations Data-Driven Culture Enables rapid data-driven decision making for process issues aided by uniformity Bio4CTM ProcessPad Solution Common Challenges Customer Needs *OOT – Out of Trend
  • 28. Use Case: Process Monitoring, Troubleshooting and Optimization  Live monitoring of machines only available on plant floor; not easily accessible to Process/MSAT Engineers; interfaces lack analytics capability  No easy-to-use statistical tools for routine data analysis to increase process understanding  PD, scale-up and manufacturing data remains scattered  OOTs often go unnoticed and without corrective action, it may lead to OOS  Assembly of process execution data for real time batch analytics is fragmented leading to delays in event identification  80% time spent in assembling data leaving limited time for analysis for insights  MSAT must plan experiments to gain sufficient data for process optimization Statistical Tools Process Lifecycle Management Disparate Data Sources Machine Data & Analytics Process Understanding Built-in statistical tools like Profile Overlays, Correlations, Control charts, Group Plots, ANOVA etc. Automatic data assembly & integration with timely single-window access Captures all development and commercial production data on single platform Access to streaming machine data with live batch monitoring and statistical analysis Time spent on quality analysis leads to improved process knowledge, proactive response to issues Process Optimization Reduced MSAT burden for additional experimentation for at scale/scale down models Bio4CTM ProcessPad Solution Common ChallengesCustomer Needs
  • 29. Collaborative and intuitive manufacturing intelligence tool for process understanding Out-of-the-box statistics and data analysis tools means you don’t have to be a data scientist to get the information you need Significantly increase employee productivity with increased focus on process insights and less time hunting for data Adaptable to any complexity in batch manufacturing process/products (biologics, vaccines, small molecules, gene therapies, etc.) Minimal learning curve – easy to use, intuitive browser-based interface Low maintenance, easy to deploy, scalable browser- based platform Trusted single source of truth for all process execution data Purpose built for the biopharma industry designed by bioprocess engineers Promote data-driven decision making culture within manufacturing and quality organization Tool to promote unified process communication language at all levels of the organization Key Product Highlights Accessibility to all PD and MFG data – on a single platform Vendor agnostic with ability to connect to multi brand process equipment and electronic databases
  • 30. The vibrant M, Millipore, MilliporeSigma, BioContinuum, and Bio4C are trademarks of Merck KGaA, Darmstadt, Germany or its affiliates. All other trademarks are the property of their respective owners. Detailed information on trademarks is available via publicly accessible resources. © 2020 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.
  • 31. Bio4CTM ProcessPad Software Resources Questions

Editor's Notes

  1. This slide is mandatory for use in webinars. Place immediately after the title slide
  2. BPOG is an active industry consortium driving the paradigm shift. Most of our customers will be familiar with the BPOG technology roadmap. Use this slide to foster discussion on their position and drivers for adopting new technologies. 1. The market trends illustrated here are what is driving the paradigm shift towards next generation bioprocessing. 2. The market trends are pushing the need for a radical step change in business drivers. The targets required by the industry require massive shifts in technology and approaches for bioprocessing. 3. Our program is designed to enable the step change in business drivers through technologies that will deliver intensified processing. Key technologies still need to evolve to deliver these aggressive targets. Process intensification Analytics S&A Single use technologies 4. Merck is strategically focused to deliver these enablers through our focused initiatives: BioContinuum, Digital BioP and Single Use
  3. Unified process language from operator to top level management